For doctors

Thyroid cancer: trials for referral

266 open trials in the registries we read. Each row links to its registry record.

Registry data only. Frontlight does not judge whether a patient can take part: the trial team decides.

Thyroid cancer·What we know·Glossary

Where the open trials are

Type a city to sort by distance. The distance is worked out in your browser; the city is not sent anywhere.

Your city

Only trials with a pre-treatment window

266 trials shown

Phase 1/21 site
Not yet recruitingUnited States
NCT06991738
177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Registry updated 5 Nov 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
No phase1 site
RecruitingUnited States
NCT01005654
Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
National Cancer Institute (NCI)
Registry updated 5 Nov 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 21 site
RecruitingChina
NCT06359847
Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer
Beijing Scitech-Mq Pharmaceuticals Limited
Registry updated 5 Nov 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
No phase1 site
RecruitingUnited States
NCT05229341
Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
City of Hope Medical Center
Registry updated 5 Nov 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
No phase1 site
RecruitingUnited States
NCT03160274
Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
The University of Texas Health Science Center at San Antonio
Registry updated 5 Nov 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
No phase2 sites
RecruitingUnited States
NCT01247597
DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study
National Cancer Institute (NCI)
Registry updated 5 Nov 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 25 sites
RecruitingUnited States
NCT06959511
Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
M.D. Anderson Cancer Center
Registry updated 5 Nov 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
No phase1 site
RecruitingUnited States
NCT01109420
Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Registry updated 5 Nov 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 21 site
RecruitingUnited States
NCT04927416
The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Registry updated 5 Nov 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
No phase1 site
RecruitingUnited States
NCT02609685
Active Surveillance of Papillary Thyroid Microcarcinoma
Cedars-Sinai Medical Center
Registry updated 4 Nov 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
No phase17 sites
RecruitingUnited States
NCT05366881
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Adela, Inc
Registry updated 4 Nov 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
No phase1 site
RecruitingChina
NCT07914764
68Ga-labeled Cholecystokinin Receptor (CCK2R) Targeted Molecular Probes in Early Tumor Diagnosis
Nanjing First Hospital, Nanjing Medical University
Registry updated 4 Nov 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 31 site
RecruitingUnited States
NCT05999630
Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated With Radioactive Iodine for Thyroid Cancer
Vanderbilt University Medical Center
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
No phase1 site
RecruitingItaly
NCT05766098
Definition of Mutational Profile of Papillary Thyroid Tumors by Mass-ARRAY
Istituto Auxologico Italiano
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
No phase1 site
By invitation onlyDenmark
NCT07909603
Head and Neck Cancer Strategies
Aarhus University Hospital
Registry updated 2 Nov 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
No phase1 site
Not yet recruiting
NCT07907432
Serum Treg/Th17-Related Cytokines and Systemic Inflammatory Indices in Differentiated Thyroid Cancer
Marmara University
Registry updated 2 Nov 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 21 site
RecruitingUnited States
NCT03841617
The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Registry updated 29 Oct 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
No phase1 site
RecruitingUnited States
NCT00001160
Studies on Tumors of the Thyroid
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Registry updated 29 Oct 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 10 sites
Not yet recruiting
NCT07252661
Study of ACC-1898 in Adult Participants With Advanced Solid Tumors
AccSalus Biosciences, Inc.
Registry updated 28 Oct 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 11 site
RecruitingNetherlands
NCT07485569
Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial
Radboud University Medical Center
Registry updated 28 Oct 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 34 sites
By invitation onlyUnited States
NCT07620574
Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study
Exelixis
Registry updated 28 Oct 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
No phase1 site
RecruitingUnited States
NCT03382158
International PPB/DICER1 Registry
Children's Hospitals and Clinics of Minnesota
Registry updated 26 Oct 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
No phase1 site
RecruitingFrance
NCT03410394
Registry of Endocrine Tumors (Thyroid, Parathyroid, Adrenal, Endocrine Pancreas, Endocrine Digestive Tube)
Central Hospital, Nancy, France
Registry updated 22 Oct 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 21 site
Not yet recruitingUnited States
NCT07886905
Pulsed Stereotactic Ablative Radiotherapy (PULSAR) With Systematic Therapy for Thyroid Cancer
Washington University School of Medicine
Pre-treatment window Registry sentence: “Prior systemic therapy for thyroid cancer.”
Registry updated 21 Oct 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 32 sites
RecruitingPoland
NCT05468554
Evaluation of Metformin Effect on the Fertility of Women Treated With 131I for Thyroid Cancer
Medical University of Bialystok
Registry updated 21 Oct 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 26 sites
RecruitingUnited States
NCT05783323
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Children's Hospital of Philadelphia
Pre-treatment window Registry sentence: “No prior systemic therapy for thyroid cancer, including tropomyosin receptor kinase (TRK) inhibitors.”
Registry updated 21 Oct 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
No phase1 site
Not yet recruitingUnited States
NCT07612293
STAGE-MTC Trial Thyroid Lobectomy With Ipsilateral Central Neck Dissection
Jonsson Comprehensive Cancer Center
Registry updated 19 Oct 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 27 sites
RecruitingUnited States
NCT06007924
A Study of Avutometinib and Defactinib in People With Thyroid Cancer
Memorial Sloan Kettering Cancer Center
Registry updated 15 Oct 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
Phase 1/26 sites
RecruitingUnited States
NCT06239194
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
ModeX Therapeutics, An OPKO Health Company
Registry updated 15 Oct 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site
No phase1 site
Not yet recruitingUnited States
NCT07529080
Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial
University of Michigan Rogel Cancer Center
Registry updated 15 Oct 2026
Registry record: ClinicalTrials.gov
Referral pack Letter to the site

271 sites Pre-treatment window

The same sites as a list

China82 open trials
United States76 open trials
Italy22 open trials
France11 open trials
Spain9 open trials
United Kingdom9 open trials
Netherlands8 open trials
Canada8 open trials
South Korea7 open trials
Denmark6 open trials
Australia5 open trials
Japan5 open trials
Egypt4 open trials
Germany3 open trials
Norway3 open trials
Singapore3 open trials
Poland2 open trials
Hong Kong SAR China2 open trials
Mexico2 open trials
Sweden2 open trials
Hungary2 open trials
Belgium2 open trials
Russia2 open trials
Taiwan2 open trials
India1 open trials
Malaysia1 open trials
Switzerland1 open trials
Croatia1 open trials
Romania1 open trials
Brazil1 open trials
Colombia1 open trials

Who treats this

Institutions with trials or publications in this disease (OpenAlex, registries). Institutions only, no people.

Affiliated Hospital of Qingdao University
Qingdao, China
0 trials · 34 publications · ROR
Affiliated Hospital of Southwest Medical University
Luzhou, China
0 trials · 28 publications · ROR
Agostino Gemelli University Polyclinic
Rome, Italy
0 trials · 38 publications · ROR
Alexandria University
Alexandria, Egypt
0 trials · 39 publications · ROR
All India Institute of Medical Sciences
New Delhi, India
2 trials · 31 publications · ROR
Aristotle University of Thessaloniki
Thessaloniki, Greece
1 trials · 33 publications · ROR
Asan Medical Center
Seoul, South Korea
4 trials · 36 publications · ROR
Baylor College of Medicine
Houston, United States
0 trials · 36 publications · ROR
Brigham and Women's Hospital
Boston, United States
3 trials · 49 publications · ROR
Cairo University
Giza, Egypt
0 trials · 28 publications · ROR
Cancer Hospital of Chinese Academy of Medical Sciences
Beijing, China
0 trials · 39 publications · ROR
Capital Medical University
Beijing, China
0 trials · 54 publications · ROR
Case Western Reserve University
Cleveland, United States
1 trials · 37 publications · ROR
Catholic University of Korea
Seoul, South Korea
0 trials · 51 publications · ROR
Central South University
Changsha, China
0 trials · 86 publications · ROR
Centre international de recherche sur le cancer
Lyon, France
0 trials · 26 publications · ROR
Centre National de la Recherche Scientifique
Paris, France
0 trials · 47 publications · ROR
Children's Hospital of Philadelphia
Philadelphia, United States
7 trials · 34 publications · ROR
China Medical University
Shenyang, China
0 trials · 44 publications · ROR
China-Japan Friendship Hospital
Beijing, China
1 trials · 31 publications · ROR
Chinese Academy of Medical Sciences & Peking Union Medical College
Beijing, China
0 trials · 149 publications · ROR
Chinese Academy of Sciences
Beijing, China
0 trials · 55 publications · ROR
Chinese People's Liberation Army
Beijing, China
0 trials · 46 publications · ROR
Chinese PLA General Hospital
Beijing, China
3 trials · 41 publications · ROR
Chongqing University
Chongqing, China
0 trials · 34 publications · ROR
Chung-Ang University
Seoul, South Korea
0 trials · 27 publications · ROR
City Of Hope National Medical Center
Duarte, United States
2 trials · 30 publications · ROR
Cleveland Clinic
Cleveland, United States
4 trials · 62 publications · ROR
Consejo Nacional de Investigaciones Científicas y Técnicas
Buenos Aires, Argentina
0 trials · 24 publications · ROR
Dana-Farber Cancer Institute
Boston, United States
18 trials · 47 publications · ROR
Division of Cancer Epidemiology and Genetics
Bethesda, United States
0 trials · 42 publications · ROR
Duke Medical Center
Durham, United States
5 trials · 25 publications · ROR
Duke University
Durham, United States
0 trials · 37 publications · ROR
Emory University
Atlanta, United States
3 trials · 35 publications · ROR
Erasmus MC
Rotterdam, Netherlands
0 trials · 38 publications · ROR
Federico II University Hospital
Naples, Italy
0 trials · 25 publications · ROR
First Affiliated Hospital of Anhui Medical University
Hefei, China
0 trials · 27 publications · ROR
First Affiliated Hospital of Zhengzhou University
Zhengzhou, China
0 trials · 34 publications · ROR
First Affiliated Hospital Zhejiang University
Hangzhou, China
0 trials · 31 publications · ROR
First Hospital of China Medical University
Shenyang, China
0 trials · 58 publications · ROR
First Hospital of Shanxi Medical University
Taiyuan, China
0 trials · 25 publications · ROR
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Italy
10 trials · 30 publications · ROR
Fudan University
Shanghai, China
0 trials · 103 publications · ROR
Fudan University Shanghai Cancer Center
Shanghai, China
12 trials · 47 publications · ROR
Fujian Medical University
Fuzhou, China
0 trials · 73 publications · ROR
German Cancer Research Center
Heidelberg, Germany
0 trials · 28 publications · ROR
Hacettepe University
Ankara, Türkiye
0 trials · 27 publications · ROR
Hangzhou Medical College
Hangzhou, China
0 trials · 61 publications · ROR
Hanyang University
Seoul, South Korea
0 trials · 25 publications · ROR
Harbin Medical University
Harbin, China
1 trials · 48 publications · ROR
Harvard University
Cambridge, United States
0 trials · 145 publications · ROR
Henan Cancer Hospital
Zhengzhou, China
6 trials · 27 publications · ROR
Homi Bhabha National Institute
Mumbai, India
0 trials · 24 publications · ROR
Huazhong University of Science and Technology
Wuhan, China
0 trials · 67 publications · ROR
Hunan Cancer Hospital
Changsha, China
6 trials · 32 publications · ROR
Huntsman Cancer Institute
Salt Lake City, United States
7 trials · 25 publications · ROR
Icahn School of Medicine at Mount Sinai
New York, United States
2 trials · 47 publications · ROR
Imperial College London
London, United Kingdom
0 trials · 34 publications · ROR
Inserm
Paris, France
0 trials · 86 publications · ROR
Institut Gustave Roussy
Villejuif, France
13 trials · 49 publications · ROR
Iran University of Medical Sciences
Tehran, Iran
0 trials · 27 publications · ROR
IRCCS Istituto Auxologico Italiano
Milan, Italy
3 trials · 34 publications · ROR
Istanbul University
Istanbul, Türkiye
0 trials · 33 publications · ROR
Istanbul University-Cerrahpaşa
Istanbul, Türkiye
0 trials · 25 publications · ROR
Istituti di Ricovero e Cura a Carattere Scientifico
Rome, Italy
0 trials · 36 publications · ROR
Jagiellonian University
Krakow, Poland
0 trials · 33 publications · ROR
Jiangsu Province Hospital
Nanjing, China
0 trials · 41 publications · ROR
Jilin University
Changchun, China
0 trials · 42 publications · ROR
Johns Hopkins Medicine
Baltimore, United States
0 trials · 30 publications · ROR
Johns Hopkins University
Baltimore, United States
2 trials · 58 publications · ROR
Karolinska Institutet
Stockholm, Sweden
0 trials · 55 publications · ROR
Karolinska University Hospital
Stockholm, Sweden
2 trials · 28 publications · ROR
King Abdulaziz University
Jeddah, Saudi Arabia
0 trials · 24 publications · ROR
King Faisal Specialist Hospital & Research Centre
Riyadh, Saudi Arabia
0 trials · 31 publications · ROR
King Saud University
Riyadh, Saudi Arabia
0 trials · 29 publications · ROR
Korea University
Seoul, South Korea
0 trials · 25 publications · ROR
Lanzhou University
Lanzhou, China
0 trials · 25 publications · ROR
Ludwig-Maximilians-Universität München
Munich, Germany
0 trials · 27 publications · ROR
Mansoura University
Al Mansurah, Egypt
1 trials · 32 publications · ROR
Martin Luther University Halle-Wittenberg
Halle, Germany
0 trials · 35 publications · ROR
Mashhad University of Medical Sciences
Mashhad, Iran
0 trials · 28 publications · ROR
Massachusetts General Hospital
Boston, United States
12 trials · 79 publications · ROR
Mayo Clinic
Rochester, United States
8 trials · 105 publications · ROR
Mayo Clinic in Florida
Jacksonville, United States
7 trials · 29 publications · ROR
McGill University
Montreal, Canada
0 trials · 34 publications · ROR
Memorial Sloan Kettering Cancer Center
New York, United States
33 trials · 108 publications · ROR
Michigan Medicine
Ann Arbor, United States
0 trials · 33 publications · ROR
Ministry of Health of the Russian Federation
Moscow, Russia
0 trials · 36 publications · ROR
Moffitt Cancer Center
Tampa, United States
5 trials · 30 publications · ROR
Nanchang University
Nanchang, China
0 trials · 34 publications · ROR
Nanjing Medical University
Nanjing, China
0 trials · 84 publications · ROR
Nanjing University
Nanjing, China
0 trials · 26 publications · ROR
Nanjing University of Chinese Medicine
Nanjing, China
0 trials · 33 publications · ROR
Nankai University
Tianjin, China
0 trials · 29 publications · ROR
National Academy of Medical Sciences of Ukraine
Kyiv, Ukraine
0 trials · 33 publications · ROR
National and Kapodistrian University of Athens
Athens, Greece
0 trials · 32 publications · ROR
National Cancer Center
Goyang-si, South Korea
4 trials · 46 publications · ROR
National Cancer Institute
Bethesda, United States
0 trials · 80 publications · ROR
National Institutes of Health
Bethesda, United States
0 trials · 85 publications · ROR
National University of Singapore
Singapore, Singapore
0 trials · 26 publications · ROR
Oregon Health & Science University
Portland, United States
4 trials · 25 publications · ROR
Peking Union Medical College Hospital
Beijing, China
9 trials · 68 publications · ROR
Peking University
Beijing, China
0 trials · 25 publications · ROR
Peking University Cancer Hospital
Beijing, China
7 trials · 35 publications · ROR
Princess Margaret Cancer Centre
Toronto, Canada
5 trials · 27 publications · ROR
Qingdao University
Qingdao, China
0 trials · 29 publications · ROR
Radboud University Medical Center
Nijmegen, Netherlands
2 trials · 36 publications · ROR
Royal North Shore Hospital
St Leonards, Australia
2 trials · 34 publications · ROR
Ruijin Hospital
Shanghai, China
0 trials · 40 publications · ROR
Sağlık Bilimleri Üniversitesi
Istanbul, Türkiye
0 trials · 54 publications · ROR
Samsung Medical Center
Seoul, South Korea
7 trials · 39 publications · ROR
Sapienza University of Rome
Rome, Italy
0 trials · 51 publications · ROR
Seoul National University
Seoul, South Korea
0 trials · 101 publications · ROR
Seoul National University Hospital
Seoul, South Korea
13 trials · 60 publications · ROR
Shahid Beheshti University
Tehran, Iran
0 trials · 38 publications · ROR
Shahid Beheshti University of Medical Sciences
Tehran, Iran
0 trials · 48 publications · ROR
Shandong First Medical University
Jinan, China
0 trials · 54 publications · ROR
Shandong University
Jinan, China
0 trials · 36 publications · ROR
Shanghai Jiao Tong University
Shanghai, China
0 trials · 132 publications · ROR
Shanghai Medical College of Fudan University
Shanghai, China
0 trials · 45 publications · ROR
Shanghai Sixth People's Hospital
Shanghai, China
5 trials · 51 publications · ROR
Shanghai Tenth People's Hospital
Shanghai, China
0 trials · 33 publications · ROR
Shanxi Medical University
Taiyuan, China
0 trials · 54 publications · ROR
Sichuan Cancer Hospital
Chengdu, China
1 trials · 29 publications · ROR
Sichuan University
Chengdu, China
0 trials · 94 publications · ROR
Sir Run Run Shaw Hospital
Hangzhou, China
1 trials · 25 publications · ROR
Sorbonne Université
Paris, France
0 trials · 29 publications · ROR
Southern Medical University
Guangzhou, China
0 trials · 56 publications · ROR
Southwest Medical University
Luzhou, China
0 trials · 32 publications · ROR
Stanford Medicine
Stanford, United States
0 trials · 51 publications · ROR
Stanford University
Stanford, United States
2 trials · 67 publications · ROR
State Key Laboratory of Oncology in South China
Guangzhou, China
0 trials · 28 publications · ROR
Sun Yat-sen University
Guangzhou, China
0 trials · 72 publications · ROR
Sun Yat-sen University Cancer Center
Guangzhou, China
5 trials · 42 publications · ROR
Sungkyunkwan University
Suwon, South Korea
0 trials · 48 publications · ROR
Tata Memorial Hospital
Mumbai, India
1 trials · 26 publications · ROR
Tehran University of Medical Sciences
Tehran, Iran
0 trials · 55 publications · ROR
The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, China
0 trials · 35 publications · ROR
The Maria Sklodowska-Curie National Research Institute of Oncology
Warsaw, Poland
0 trials · 34 publications · ROR
The Ohio State University
Columbus, United States
0 trials · 54 publications · ROR
The University of Sydney
Sydney, Australia
0 trials · 60 publications · ROR
The University of Texas MD Anderson Cancer Center
Houston, United States
4 trials · 167 publications · ROR
The University of Texas Southwestern Medical Center
Dallas, United States
0 trials · 37 publications · ROR
Tianjin Medical University
Tianjin, China
0 trials · 50 publications · ROR
Tianjin Medical University Cancer Institute and Hospital
Tianjin, China
2 trials · 74 publications · ROR
Tongji University
Shanghai, China
0 trials · 49 publications · ROR
Universidade de São Paulo
São Paulo, Brazil
0 trials · 59 publications · ROR
Università Cattolica del Sacro Cuore
Milan, Italy
1 trials · 27 publications · ROR
Université Paris-Saclay
Gif-sur-Yvette, France
0 trials · 34 publications · ROR
University Health Network
Toronto, Canada
4 trials · 31 publications · ROR
University Medical Center Groningen
Groningen, Netherlands
3 trials · 33 publications · ROR
University Medical Center Utrecht
Utrecht, Netherlands
2 trials · 28 publications · ROR
University of Alabama at Birmingham
Birmingham, United States
2 trials · 35 publications · ROR
University of Bologna
Bologna, Italy
0 trials · 28 publications · ROR
University of California, Los Angeles
Los Angeles, United States
1 trials · 63 publications · ROR
University of California, San Francisco
San Francisco, United States
5 trials · 40 publications · ROR
University of Colorado Anschutz
Aurora, United States
1 trials · 38 publications · ROR
University of Copenhagen
Copenhagen, Denmark
0 trials · 37 publications · ROR
University of Electronic Science and Technology of China
Chengdu, China
0 trials · 34 publications · ROR
University of Florida
Gainesville, United States
1 trials · 37 publications · ROR
University of Florida Health
Gainesville, United States
0 trials · 24 publications · ROR
University of Groningen
Groningen, Netherlands
0 trials · 25 publications · ROR
University of Messina
Messina, Italy
0 trials · 27 publications · ROR
University of Miami
Coral Gables, United States
0 trials · 41 publications · ROR
University of Michigan
Ann Arbor, United States
6 trials · 76 publications · ROR
University of Milan
Milan, Italy
0 trials · 55 publications · ROR
University of Minnesota
Minneapolis, United States
0 trials · 25 publications · ROR
University of Naples Federico II
Naples, Italy
0 trials · 53 publications · ROR
University of North Carolina at Chapel Hill
Chapel Hill, United States
1 trials · 40 publications · ROR
University of Padua
Padua, Italy
0 trials · 28 publications · ROR
University of Pavia
Pavia, Italy
0 trials · 30 publications · ROR
University of Pennsylvania
Philadelphia, United States
2 trials · 71 publications · ROR
University of Pisa
Pisa, Italy
0 trials · 49 publications · ROR
University of Pittsburgh
Pittsburgh, United States
0 trials · 29 publications · ROR
University of Southern California
Los Angeles, United States
0 trials · 44 publications · ROR
University of Toronto
Toronto, Canada
0 trials · 64 publications · ROR
University of Turin
Turin, Italy
0 trials · 29 publications · ROR
University of Ulsan
Ulsan, South Korea
0 trials · 36 publications · ROR
University of Utah
Salt Lake City, United States
0 trials · 33 publications · ROR
University of Washington
Seattle, United States
0 trials · 43 publications · ROR
University of Wisconsin–Madison
Madison, United States
0 trials · 32 publications · ROR
UNSW Sydney
Sydney, Australia
0 trials · 25 publications · ROR
V.P. Komisarenko Institute of Endocrinology and Metabolism
Kyiv, Ukraine
0 trials · 33 publications · ROR
Vanderbilt University Medical Center
Nashville, United States
4 trials · 31 publications · ROR
Weill Cornell Medicine
New York, United States
0 trials · 43 publications · ROR
Wenzhou Medical University
Wenzhou, China
0 trials · 57 publications · ROR
West China Hospital of Sichuan University
Chengdu, China
1 trials · 92 publications · ROR
West China Medical Center of Sichuan University
Chengdu, China
0 trials · 34 publications · ROR
Wuhan Union Hospital
Wuhan, China
0 trials · 34 publications · ROR
Xi'an Jiaotong University
Xi'an, China
0 trials · 32 publications · ROR
Xiamen University
Xiamen, China
0 trials · 24 publications · ROR
Xiangya Hospital Central South University
Changsha, China
0 trials · 49 publications · ROR
Yale University
New Haven, United States
7 trials · 40 publications · ROR
Yonsei University
Seoul, South Korea
0 trials · 65 publications · ROR
Yonsei University Health System
Seoul, South Korea
0 trials · 33 publications · ROR
Zhejiang Cancer Hospital
Hangzhou, China
10 trials · 51 publications · ROR
Zhejiang Chinese Medical University
Hangzhou, China
0 trials · 43 publications · ROR
Zhejiang Provincial People's Hospital
Hangzhou, China
8 trials · 61 publications · ROR
Zhejiang University
Hangzhou, China
0 trials · 94 publications · ROR
Zhengzhou University
Zhengzhou, China
0 trials · 59 publications · ROR

What changed in the last 7 days

RSS feed (30 days)Calendar reminder

Registry facts, one per line, newest first.

28 Oct 2026
Opened for recruitment
Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial
NCT07485569 · Phase 1 · Netherlands
Source: ClinicalTrials.gov
22 Sept 2026
Opened for recruitment
Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
NCT07006727 · Phase 1 · Canada, Germany, Spain, France, Italy, Japan
Source: ClinicalTrials.gov
30 Jan 2026
Phase changed: Phase 1 → Early Phase 1
[177Lu]Lu-AKIR001 First-in-human Study
NCT06639191 · Early Phase 1 · Sweden
Source: ClinicalTrials.gov
21 Nov 2025
Phase changed: Phase 1/2 → Phase 1
A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid Tumors
NCT05668585 · Phase 1 · Germany, Spain, France, United Kingdom, Italy, United States
Source: ClinicalTrials.gov
27 Jun 2025
Phase changed: Phase 1/2 → Phase 2
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
NCT03175224 · Phase 2 · Australia, Canada, Spain, France, United Kingdom, Hungary
Source: ClinicalTrials.gov
22 Jul 2026
Status changed: Recruiting → Not yet recruiting
Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial
NCT07485569 · Phase 1 · Netherlands
Source: ClinicalTrials.gov
9 Sept 2026
Status changed: Recruiting → Not yet recruiting
Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
NCT07006727 · Phase 1 · Canada, Germany, Spain, France, Italy, Japan
Source: ClinicalTrials.gov
4 Nov 2026
New in the registry
68Ga-labeled Cholecystokinin Receptor (CCK2R) Targeted Molecular Probes in Early Tumor Diagnosis
NCT07914764 · No phase · China
Source: ClinicalTrials.gov

New reviews, guidelines and randomised trials in PubMed

5 Nov 2026
Systematic review
Diagnostic limitations and procedure-related implantation in follicular-patterned thyroid tumors: a focused review with two illustrative cases.
Frontiers in endocrinology · PubMed
4 Nov 2026
Systematic review
A systematic review on the possible role of microRNA-155 in cancer treatment.
Frontiers in pharmacology · PubMed
3 Nov 2026
Randomised trial
[Clinical exploration of near-infrared autofluorescence imaging for parathyroid gland preservation in thyroid cancer surgery].
Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · PubMed

Results card

Trials that finished or stopped in the last 3 years, with the reason the registry gives and linked publications.

Phase 1Ended 30 Oct 2026
Completed18 participants
NCT03435952
Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT
Registry record
No phaseEnded 4 Aug 2026
Completed874 participants
NCT07255482
Mortality Benefit of Ultrasound for Thyroid Nodules Identified With PET Imaging: Non-Inferiority Emulated Target Trial
Registry record
No phaseEnded 31 Jul 2026
Completed300 participants
NCT07524777
Ganoderma Spores Modulate the Gut-Brain Axis
Registry record
Phase 1Ended 3 Jun 2026
Completed70 participants
NCT05241834
A Study of LOXO-260 in Cancer Patients With a Change in a Particular Gene (RET) That Has Not Responded to Treatment
Registry record
Phase 1/2Ended 2 Jun 2026
Completed98 participants
NCT05864144
A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors
Registry record
No phaseEnded 31 May 2026
Completed98 participants
NCT07652450
Incidental Thyroid Cancer in Cases With Inflammatory Thyroid Lesion
Registry record
Phase 2Ended 27 May 2026
Completed29 participants
NCT04321954
Lenvatinib in Locally Advanced Invasive Thyroid Cancer
Registry record
No phaseEnded 15 May 2026
Completed32 participants
NCT07623005
Progressive Muscle Relaxation for Pain and Quality of Life in Thyroid Cancer
Registry record
No phaseEnded 22 Apr 2026
Completed250 participants
NCT05078853
Thyroglobulin Point of Care Assay for Rapid Detection of Metastatic Differentiated Thyroid Carcinoma
Registry record
No phaseEnded 4 Apr 2026
Completed15 participants
NCT07543887
Selpercatinib and Body Composition
Registry record
No phaseEnded 15 Mar 2026
Completed74 participants
NCT07488858
Thyroidectomy: Microscopic Versus Conventional
Registry record
Phase 2Ended 12 Mar 2026
Completed100 participants
NCT07911891
Oral Mecobalamin for TKI-Associated Hand-Foot Syndrome in Advanced Thyroid Cancer
Registry record
No phaseEnded 23 Feb 2026
Completed124 participants
NCT07752277
Quantitative Pharmacology-Based Dose Adjustment Protocol in Postoperative Thyroid Cancer Patients
Registry record
Phase 3Ended 31 Jan 2026
Completed390 participants
NCT04964284
rhTSH for Radioactive Iodine Remnant Ablation in Participants With Differentiated Thyroid Cancer (DTC)
Registry record
No phaseEnded 30 Jan 2026
Completed2 participants
NCT06235814
Molecular Analysis for Precision Surgery in Thyroid Cancer Trial
Registry record
Phase 2Ended 15 Jan 2026
Completed40 participants
NCT03244956
Efficacy of MEK (Trametinib) and BRAFV600E (Dabrafenib) Inhibitors With Radioactive Iodine (RAI) for the Treatment of Refractory Metastatic Differentiated Thyroid Cancer
- Lesional dosimetry in 131I refractory metastatic differentiated thyroid cancer with BRAFp.V600E or RAS mutation treated with trametinib +/- dabrafenib followed by radioactive iodine. · Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB), 2026
- MERAIODE: A Phase II Redifferentiation Trial with Trametinib and 131I in Metastatic Radioactive Iodine Refractory RAS Mutated Differentiated Thyroid Cancer. · Thyroid : official journal of the American Thyroid Association, 2023
Registry record
No phaseEnded 31 Dec 2025
Completed27 participants
NCT07506161
Radiofrequency Ablation Treatment of Low-Risk Papillary Thyroid Carcinomas
Registry record
No phaseEnded 31 Dec 2025
Completed549 participants
NCT04593277
Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study
Registry record
No phaseEnded 22 Dec 2025
Completed84 participants
NCT04522570
Thermal Ablation of Cervical Metastases From Thyroid Carcinoma
Registry record
No phaseEnded 20 Dec 2025
Completed50 participants
NCT06073223
Intervention to Decrease Overtreatment of Patients With Low-risk Thyroid Cancer
Registry record
Phase 1/2Ended 18 Dec 2025
Completed40 participants
NCT05708950
A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Registry record
No phaseEnded 1 Dec 2025
Completed33 participants
NCT05280379
Trained Immunity in Thyroid Carcinoma and Colon Carcinoma
Registry record
Phase 2Ended 30 Nov 2025
Completed41 participants
NCT05660954
Cabozantinib In Advanced Radioactive-Iodine Refractory Differentiated Thyroid Cancer.
Registry record
Phase 1/2Ended 13 Nov 2025
Completed33 participants
NCT05745363
Clinical Study of AL2846 Capsule in the Treatment of Differentiated Thyroid Cancer
Registry record
No phaseEnded 10 Nov 2025
Completed58 participants
NCT07274670
Superficial Cervical Plexus Block With Dexmedetomidine Versus Without Adjuvant in Thyroid Surgery
Registry record
Phase 1Ended 5 Nov 2025
Completed89 participants
NCT05668585
A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid Tumors
Registry record
No phaseEnded 3 Nov 2025
Completed49 participants
NCT07298187
The Effect of Head Position on the Optik Nerve Sheath Diameter in Patients During Thyroid Surgery
Registry record
No phaseEnded 15 Oct 2025
Completed515 participants
NCT06498674
AI-Assisted Ultrasound Review Before Thyroid Surgery
Registry record
No phaseEnded 5 Oct 2025
Completed63 participants
NCT06171945
Mobile Weight Loss Intervention for Adolescent and Young Adult Cancer Survivors
Registry record
Phase 1Ended 2 Oct 2025
Completed20 participants
NCT00673010
Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma
Registry record
No phaseEnded 29 Sept 2025
Completed603 participants
NCT04000880
Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health
Registry record
Phase 2Ended 29 Sept 2025
Completed215 participants
NCT02576431
A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
- Cancer control after pausing treatment with larotrectinib in responding children with sarcoma and a TRK fusion: a plain language summary. · Future oncology (London, England), 2026
Registry record
No phaseEnded 19 Sept 2025
Completed66 participants
NCT07659717
Frozen Section-Guided Selective Ipsilateral Central Neck Dissection in Bethesda V-VI Thyroid Nodules
Registry record
Phase 4Ended 4 Sept 2025
Completed50 participants
NCT03573960
A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer
Registry record
Phase 1Ended 11 Aug 2025
Completed45 participants
NCT05851560
Prospective Comparison of the Effect on Antiadhesive Barriers During Thyroid Surgery
Registry record
No phaseEnded 8 Aug 2025
Completed33 participants
NCT06582849
Enhanced Assistance During Radiotherapy for Unmet Essential Needs
Registry record
No phaseEnded 5 Jul 2025
Completed80 participants
NCT05265819
Effect of Exergaming Exercises and Mediterranean Diet on Thyroid Cancer Patients Following Total Thyroidectomy
Registry record
No phaseEnded 6 Jun 2025
Completed82 participants
NCT04481893
Interest of the Virtual Reality Headset in the Management of Perioperative Stress in Patients Candidates for Total Thyroidectomy
Registry record
No phaseEnded 31 May 2025
Completed143 participants
NCT07575243
Thyroidectomy-specific Enhanced Recovery After Surgery (ERAS) Protocol
Registry record
No phaseEnded 31 May 2025
Completed430 participants
NCT06958601
Safety and Efficacy of Transoral Robotic Thyroidectomy Versus Traditional Open Thyroidectomy for Thyroid Cancer
Registry record
No phaseEnded 31 May 2025
Completed100 participants
NCT05752669
Oxidative Stress and Mitochondrial TERT in Papillary Thyroid Cancer.
Registry record
Phase 2/3Ended 7 May 2025
Completed372 participants
NCT03498183
Value of the Combination Ultrasonography With Ti-RADS Score / Dual Tracer Scintigraphy MIBI-Tc99m/Iodine-123 in the Detection of Malignancy of Thyroid Nodules (≥15 mm) Classified Bethesda III or IV on Cytology
Registry record
No phaseEnded 1 May 2025
Completed100 participants
NCT07911761
Prophylactic Central Neck Dissection for Papillary Thyroid Carcinoma
Registry record
No phaseEnded 31 Mar 2025
Completed138 participants
NCT05789667
Gender-based Impact on Safety and Efficacy of Lenvatinib in Patients With Differentiated Thyroid Cancer
Registry record
Phase 1Ended 31 Mar 2025
Completed11 participants
NCT05275946
Targeted Alpha Therapy Using Astatine (At-211) Against Differentiated Thyroid Cancer
Registry record
Phase 1Ended 27 Mar 2025
Completed12 participants
NCT05410821
Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid Cancer
Registry record
Phase 3Ended 13 Mar 2025
Completed205 participants
NCT01298323
Study to Determine if Contacting Patients With MTC More Frequently Results in Earlier Detection and Treatment of Signs and Symptoms of AEs and Thus a Decrease in the Percentage of Time Patients Experience AEs During First 12 Months on Vandetanib Treatment
Registry record
Phase 1Ended 10 Mar 2025
Completed12 participants
2024-514496-18-01
An open-label, prospective, randomised, cross-over trial to assess the pharmacokinetics of an amorphous formulation of sorafenib in mesoporous magnesium carbonate (DPH001) compared to Nexavar® (sorafenib) in healthy volunteers
Registry record
No phaseEnded 9 Feb 2025
Completed1200 participants
NCT02776969
A Gene Hunting Study for Familial Papillary Thyroid Cancer
Registry record
Phase 1Ended 6 Feb 2025
Completed19 participants
NCT06048367
Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor
- Carbon nanoparticle-Fe (II) complex for ferroptosis therapy in refractory solid tumors: a phase I trial. · Signal transduction and targeted therapy, 2026
- First-in-human evidence of multidrug resistance reversal in solid tumors: a cohort analysis of carbon nanoparticles‑Fe(II) complex trials. · BMC cancer, 2026
Registry record
No phaseEnded 20 Jan 2025
Completed21 participants
NCT06793579
Lateral Approach for Mediastinal Lymph Node Dissection in Thyroid Cancer
Registry record
Phase 2Ended 5 Jan 2025
Completed9 participants
NCT04552769
Abemaciclib in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer
Registry record
Phase 4Ended 1 Jan 2025
Completed600 participants
NCT06697782
Aprepitant and Ondansetron Monotherapy or Combination for Postoperative Nausea and Vomiting in Thyroid Cancer
Registry record
No phaseEnded 1 Jan 2025
Completed332 participants
NCT07229859
Robotic Surgery Via Bilateral Axillo-breast Approach for Relatively Low-risk Papillary Thyroid Carcinoma With Lateral Cervical Lymph Node Metastasis: a Safe and Effective Cosmetic Procedure in the Context of Prevalent Thyroid Ultrasound Screening
- Robotic surgery for papillary thyroid carcinoma with lateral cervical lymph node metastasis: a hybrid design, observational, propensity score matching cohort study. · Surgical endoscopy, 2026
Registry record
No phaseEnded 31 Dec 2024
Completed181 participants
NCT06791174
Tumor Microenvironmental Collagen Signature to Predict Thyroid Cancer Superior Mediastinal Lymph Node Metastasis
Registry record
No phaseEnded 31 Dec 2024
Completed80 participants
NCT05579782
Assessing Benefits of NIRAF Detection for Identifying Parathyroid Glands During Total Thyroidectomy
Registry record
No phaseEnded 31 Dec 2024
Completed178 participants
NCT07115810
No Prognostic or Molecular Disparity Between Synchronous and Metachronous Metastases in Differentiated Thyroid Cancer: Insight From Middle Eastern Cohort
Registry record
No phaseEnded 31 Dec 2024
Completed250 participants
NCT05025046
NGS-based Thyroscan Genomic Classifier in the Diagnosis of Thyroid Nodules
Registry record
No phaseEnded 31 Dec 2024
Completed8 participants
NCT05534594
Evaluation of the 18F-PSMA Positron Emission Tomography (PET)/CT in Patients With Medullary Thyroid Cancer
Registry record
Phase 2Ended 31 Dec 2024
Completed103 participants
NCT04521348
Multiple Target Kinase Inhibitor and Anti-Programmed Death-1 Antibody in Patients With Advanced Thyroid Cancer
Registry record

Not medical advice. fetched 6 Nov 2026

Report an error